IT1t was also shown to inhibit TLR7-mediated type I interferon (IFN) signaling in human plasmacytoid dendritic cells (PDCs) from the blood and tonsils, thereby reducing inflammation in patients with systemic lupus erythematosus (SLE) [90]. The gene discussed is TLR7; the disease is systemic lupus erythematosus.